EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GH Response to Glucagon in Transition: Role of Body Mass Index and Etiology in Childhood-onset GH Deficiency

Daniela Fava iD, Stefano Parodi iD, Alessia Angelelli, Caterina Tedesco, Flavia Napoli iD, Anna Elsa Maria Allegri, Giuseppa Patti, Roberto Gastaldi iD, Chiara Santucci, Barbara Vanorio, Claudia Caridi, Nadia Gabriella Maiorano und 8 weitere

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Daniela Fava und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa 16132, Italy. Hauptthemen laut MEDLINE: Body Mass Index, Human Growth Hormone, Glucagon, Hypopituitarism. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The glucagon stimulation test (GST) is increasingly used as an alternative to the insulin tolerance test for diagnosing persistent GH deficiency (GHD) during transition, though its accuracy and appropriate cutoff values are still uncertain.

Objective

To investigate the GH response to GST in transitional-age patients with childhood-onset GHD (CO-GHD), with a focus on the influence of body mass index (BMI) and the underlying etiology. Patients and Methods A total of 180 patients with CO-GHD (median age 17.39 years) underwent GST. They were grouped based on the number of pituitary deficiencies and magnetic resonance imaging findings into isolated GHD (n = 80), organic moderate GHD (1-2 deficiencies with congenital or acquired anomalies, n = 63), and organic severe GHD (≥3 deficiencies with complex central nervous system abnormalities, n = 37). Additionally, patients were classified by BMI as normal weight, overweight, or obesity, according to age-appropriate BMI criteria. Childhood cancer survivors (CCS) accounted for 42% of the cohort.

Results

Peak GH response to GST showed a significant inverse association with the severity of pituitary dysfunction (P < .001) and an inverse correlation with BMI SD score (ρ = −0.46, P < .001). However, adjusting by disease group strongly reduced the impact of BMI on the GST response. When stratified by etiology or CCS status, GH peaks were primarily influenced by hypothalamic-pituitary damage with BMI showing a minimal effect.

Conclusion

The GST provides valuable insights into GH deficiency in transitional-age patients with CO-GHD. GH response is primarily influenced by the severity of pituitary dysfunction, with BMI playing a minimal role once adjusted for etiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Body Mass IndexHuman Growth HormoneGlucagonHypopituitarismHumansFemaleAdolescentMaleChildYoung AdultAdultAge of OnsetChild, Preschool

Stichwörter der Autor:innen

GH deficiencybrain tumorschildren cancer survivorscongenital hypopituitarismglucagontransitionyoung adults

Substanzen

Human Growth HormoneGlucagon

Autor:innen und Institutionen

  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa 16132, Italy.
  • Pediatric Endocrinology Unit, Department of Pediatrics, IRCCS Istituto Giannina Gaslini, Genoa 16147, Italy.
  • Epidemiology and Biostatistics Unit, Scientific Directorate, IRCCS Istituto Giannina Gaslini, Genoa 16147, Italy.

ORCID-Profile: Daniela Fava, Stefano Parodi, Flavia Napoli, Roberto Gastaldi, Mohamad Maghnie, Natascia Di Iorgi

Förderung

  • Italian Ministry of Health

Zitieren

APA

Fava, D., Parodi, S., Angelelli, A., Tedesco, C., Napoli, F., Allegri, A. E. M., Patti, G., Gastaldi, R., Santucci, C., Vanorio, B., Caridi, C., Maiorano, N. G., Fumo, R., Panciroli, M., Naim, A., Stefani, A., De Rose, E. L., Data, E., Maghnie, M., & Di Iorgi, N. (2026). GH Response to Glucagon in Transition: Role of Body Mass Index and Etiology in Childhood-onset GH Deficiency. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf674

Vancouver

Fava D, Parodi S, Angelelli A, Tedesco C, Napoli F, Allegri AEM, et al. GH Response to Glucagon in Transition: Role of Body Mass Index and Etiology in Childhood-onset GH Deficiency. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf674

BibTeX
@article{Fava2026,
  author = {Fava, Daniela and Parodi, Stefano and Angelelli, Alessia and Tedesco, Caterina and Napoli, Flavia and Allegri, Anna Elsa Maria and Patti, Giuseppa and Gastaldi, Roberto and Santucci, Chiara and Vanorio, Barbara and Caridi, Claudia and Maiorano, Nadia Gabriella and Fumo, Rosa and Panciroli, Marta and Naim, Alessandro and Stefani, Alessandro and De Rose, Elena Lucia and Data, Erica and Maghnie, Mohamad and Di Iorgi, Natascia},
  title = {GH Response to Glucagon in Transition: Role of Body Mass Index and Etiology in Childhood-onset GH Deficiency},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf674}
}
Kostenlos starten →